Nephritis News and Research

RSS
Nephritis is the general term used to describe inflammation of the glomerulus, tubules or interstitial tissue in the kidneys. The condition affects functioning of the kidney and its ability to filter blood and excrete waste products via the urine.
Study shows potential culprit behind Lupus

Study shows potential culprit behind Lupus

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

New study shows how a kidney biopsy can be used to tailor treatment for lupus patients

Adverse childhood experiences may contribute to poor health in adults with lupus

Adverse childhood experiences may contribute to poor health in adults with lupus

Researchers developing new tests for early detection, monitoring of lupus nephritis

Researchers developing new tests for early detection, monitoring of lupus nephritis

Synthetic peptide appears to disrupt inflammation and protect kidneys from nephritis

Synthetic peptide appears to disrupt inflammation and protect kidneys from nephritis

Lupus Research Alliance announces research awards to accelerate development of new therapies

Lupus Research Alliance announces research awards to accelerate development of new therapies

Lupus Research Alliance announces 2018 recipients of the Distinguished Innovator Award

Lupus Research Alliance announces 2018 recipients of the Distinguished Innovator Award

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Organs actively fighting back against autoimmune diseases, finds study

Organs actively fighting back against autoimmune diseases, finds study

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

FDA approves first treatment to reduce risk of NSCLC progression

FDA approves first treatment to reduce risk of NSCLC progression